Point of Care (POC) Survey Reveals Majority of U.K. Clinicians Endorse Climate Benefits of POC Through Reduction of Carbon Emissions and Anticipate Future Growth of POC Testing to Come from Community Settings

LumiraDx shares these and other findings from its first annual U.K. survey “Point of Care Diagnostics: A Clinicians View”

LumiraDx Limited (Nasdaq: LMDX) announced findings from its first annual U.K. survey, “Point of Care Diagnostics: A Clinicians View”, designed to understand clinician perspectives on the latest point of care technologies available. The U.K. blinded survey polled clinicians on a number of areas related to point of care testing (POCT) to evaluate key concerns and benefits, testing locations, environmental benefits, and funding sources.

Findings from the survey revealed a few central themes including the ongoing time and bandwidth stresses felt by the majority of clinicians, the future growth of community testing, and, importantly, an overwhelming focus on the patient impacting GP’s diagnostic decisions. In addition, the report also showed a great majority of clinicians saw the environmental value POCT brought in support of the NHS roadmap to achieve “net zero” by 2045.